Searching Content indexed under Food, Drugs, Healthcare, Life Sciences by Shon Lo ordered by Published Date Descending.
Links to Result pages
NJ Court Grants Exceptional Case Fees Based On Speculative Infringement Suit
The court then determined how much time was reasonably expended on the matter.
United States
5 Dec 2017
Court Dismisses Infringement Theory Premised On Speculated Future Formulation Changes
The US District Court for the District of New Jersey granted generic manufacturer's motion for judgment on the pleadings under Fed. R. Civ. P. 12(c) on the basis of non-infringement.
United States
23 Aug 2017
Infringement Under The Doctrine Of Equivalents
The US Court of Appeals for the Federal Circuit affirmed the finding of infringement from the US District Court for the District of Delaware under the doctrine of equivalents based on admissions from the defendant's abbreviated new drug application.
United States
10 Nov 2016
District Court Upholds Exclusivity Rights On Antibiotic Astragraf XL
Veloxis elected not to accept the FDA's proposed compromise, and sought judicial review of the FDA's decision that it would not approve Envarsus XR until Astagraf XL's exclusivity expired.
United States
3 Nov 2015
Statute Intended To Close Deepsouth Loophole Given Broad Interpretation
The asserted patents relate to DNA amplification kits. Specifically, the kits amplify "short tandem repeats" (STR) found in the human genome at locations called STR loci.
United States
3 Feb 2015
Dismissal Of Declaratory Judgment Counterclaims In Fosamax Case Vacated As Moot
Addressing the Article III case or controversy requirement in the context of the exclusivity forfeiture position of the Medicare Prescription Drug Improvement and Modernization Act of 2003 (MMA), the U.S. Court of Appeals for the Federal Circuit, in a non-precedential per curiam opinion, affirmed a district courts dismissal of Apotexs counterclaims for declaratory judgment of invalidity and non-infringement.
United States
8 Oct 2008
Links to Result pages